Susan Dell is the one running the Dells’ $10 billion giving operation—and her biggest bets are on kids, health care, and UT Austin
Reported by Fortune · fortune.com ·
Michael Dell may be one of the richest men in the world, but his wife Susan is helping decide where billions of their fortune go.
Story context
What to watch: This report cites a concrete figure ($10 billion) — compare it against the trailing trend before treating one data point as a turning point.
Latest session change: $DELL -4.58%
How this was labelled
Fortune published it, and Wook filed it under Healthcare & Pharma. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $DELL. It carried $10 billion, shown as published and not recalculated. The preview above is the publisher's own wording.
When it landed
It landed over the weekend: the change beside it is Friday's, and Monday is the first session that could react. Market holidays are not detected.
Where the price is
$DELL last traded at $451.71, -4.58% on the session. That is 24% below its 52-week high of $595.51 and 310% above its low of $110.22 — in the upper part of the range. The year's range spans 440% from low to high: a very wide band for one year, the kind of volatility where large swings are routine. These are latest-session quotes, not live prices.
How much is being written
Wook has stored 17 stories about $DELL in the last 30 days, 10 of them this week. At the 30-day pace you would expect about 4 a week, so this week is running well ahead of normal — something has drawn extra attention. Across those stories the wording ran 12% bullish, 76% neutral and 12% bearish; this one reads neutral, so it sits with the majority of the run. 2 came from Fortune and the rest from other outlets, so the coverage is broad rather than one desk returning to the story. 12 of them are listed beside this one.
The backdrop
Healthcare stories tend to turn on approvals, trial data and pricing: an FDA decision or a trial readout can move a single drugmaker sharply, while drug-pricing policy moves the whole group. On Wook's supply-chain scanner, Information Technology reads watch today — early signs of strain worth keeping an eye on.
What is already on the calendar
$DELL earnings in 38 days. These were scheduled before this story and are not caused by it.
Where to look next
The $DELL page has the full chart, the filings and the valuation model behind these figures. Comparing how two or three outlets frame the same story is the quickest way to separate the facts from the angle. Wook AI, above, can pull live figures and do the math — how far $DELL is from its high, or how this week's coverage compares — on request.
What this page is not saying
The tone and severity labels come from a fixed word list — no editor, no AI — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.